Is Mediastinoscopy Still the Gold Standard to Evaluate Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma?

Sivrikoz C. M., Ak I., Simsek F. S., Doner E., Dundar E.

THORACIC AND CARDIOVASCULAR SURGEON, vol.60, no.2, pp.116-121, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 60 Issue: 2
  • Publication Date: 2012
  • Doi Number: 10.1055/s-0030-1271148
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.116-121
  • Keywords: mediastinoscopy, FDG PET/CT, lymph node, stage, non-small cell lung carcinoma, lung cancer treatment (surgery, medical), lung cancer, diagnosis (includes staging imaging fiducials), mediastinum (incl. mediastinoscopy), positron emission tomography, PET, POSITRON-EMISSION-TOMOGRAPHY, INTEGRATED FDG-PET/CT, LYMPHADENECTOMY VAMLA, COMPUTED-TOMOGRAPHY, CANCER, CT, METASTASES
  • Eskisehir Osmangazi University Affiliated: Yes


Objectives In this study, we aimed to define the efficacy of F-18 FDG PET/CT for the detection of mediastinal lymph nodemetastases by comparing the mediastinal findings of F-18 FDG PET/CT with the histopathological results obtained either by mediastinoscopy or thoracotomy in patients with clinically operable non-small cell lung cancer (NSCLC).